Telix Pharmaceuticals (T3X.F) Q3 2025 Earnings

20AugConfirmed
Q3 2024
Q4 2024
Q1 2025
Q3 2025
-0.01
0.03
0.07
0.11

Details

Expected EPS
0.11445889932
Actual EPS
-0.005835624
Surprise EPS
-0.12
Surprise Percent
+105.1%

Description

Telix Pharmaceuticals (T3X.F) has reported earnings of -0.005835624 per share for Q3 2025.

0 Comments

Share your thoughts